MyFinsight
Home
Blog
About
Cash and cash
equivalents
$147,606K
(-7.93%↓ Y/Y)
Prepaid expenses and
other current assets
$5,813K
(113.95%↑ Y/Y)
Accounts receivable
$196K
(-44.63%↓ Y/Y)
Total current assets
$153,615K
(-5.99%↓ Y/Y)
In-process research and
development asset
$93,900K
(-37.65%↓ Y/Y)
Goodwill
$48,163K
(0.00%↑ Y/Y)
Property and equipment,
net
$11,311K
(-7.93%↓ Y/Y)
Right-of-use assets, net
$5,124K
(-0.77%↓ Y/Y)
Long-term prepaid
expenses and other assets
$4,780K
Long-term restricted cash
$1,735K
(0.00%↑ Y/Y)
Total assets
$318,628K
(-18.07%↓ Y/Y)
Accumulated deficit
-$845,786K
(-21.89%↓ Y/Y)
Accumulated other
comprehensive loss
-$4,608K
(-0.68%↓ Y/Y)
Total liabilities and
stockholders deficit
$318,628K
(-18.07%↓ Y/Y)
Total stockholders
deficit
-$125,226K
(-4855.52%↓ Y/Y)
Additional paid-in capital
$725,165K
(4.20%↑ Y/Y)
Common stock, 0.0001
par value...
$3K
(0.00%↑ Y/Y)
Total liabilities
$443,854K
(13.40%↑ Y/Y)
Contingent value rights
liability
$356,700K
(1.31%↑ Y/Y)
Long-term debt, net
$52,851K
Total current
liabilities
$20,550K
(67.67%↑ Y/Y)
Deferred tax
liabilities, net
$6,948K
(-56.95%↓ Y/Y)
Lease liabilities,
net of current...
$6,805K
(-28.81%↓ Y/Y)
Accrued expenses and
other current...
$15,142K
(88.99%↑ Y/Y)
Lease liabilities
$4,197K
(10.74%↑ Y/Y)
Accounts payable
$1,046K
(130.40%↑ Y/Y)
Warrant liability
$165K
Back
Back
Balance Sheet
Cartesian Therapeutics, Inc. (RNAC)
Cartesian Therapeutics, Inc. (RNAC)
source: myfinsight.com